Literature DB >> 33112055

The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation.

Claudia Dafinger1,2,3, Amrei M Mandel1,2, Alina Braun1,2, Heike Göbel4, Kathrin Burgmaier1, Laura Massella5, Antonio Mastrangelo6, Jörg Dötsch1, Thomas Benzing2,3,7,8, Thomas Weimbs9, Bernhard Schermer2,3,7,8, Max C Liebau1,2,3.   

Abstract

Autosomal recessive polycystic kidney disease (ARPKD) is mainly caused by variants in the PKHD1 gene, encoding fibrocystin (FC), a large transmembrane protein of incompletely understood cellular function. Here, we show that a C-terminal fragment of human FC can suppress a signalling module of the kinase SRC and signal transducer and activator of transcription 3 (STAT3). Consistently, we identified truncating genetic variants specifically affecting the cytoplasmic tail in ARPKD patients, found SRC and the cytoplasmic tail of fibrocystin in a joint dynamic protein complex and observed increased activation of both SRC and STAT3 in cyst-lining renal epithelial cells of ARPKD patients.
© 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Entities:  

Keywords:  cilia; genetic kidney diseases; polycystic kidney disease

Mesh:

Substances:

Year:  2020        PMID: 33112055      PMCID: PMC7754027          DOI: 10.1111/jcmm.16014

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.295


  16 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

2.  Synergistic Genetic Interactions between Pkhd1 and Pkd1 Result in an ARPKD-Like Phenotype in Murine Models.

Authors:  Rory J Olson; Katharina Hopp; Harrison Wells; Jessica M Smith; Jessica Furtado; Megan M Constans; Diana L Escobar; Aron M Geurts; Vicente E Torres; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2019-08-19       Impact factor: 10.121

3.  Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.

Authors:  Carsten Bergmann; Jennifer von Bothmer; Nadina Ortiz Brüchle; Andreas Venghaus; Valeska Frank; Henry Fehrenbach; Tobias Hampel; Lars Pape; Annegret Buske; Jon Jonsson; Nanette Sarioglu; Antónia Santos; Jose Carlos Ferreira; Jan U Becker; Reinhold Cremer; Julia Hoefele; Marcus R Benz; Lutz T Weber; Reinhard Buettner; Klaus Zerres
Journal:  J Am Soc Nephrol       Date:  2011-10-27       Impact factor: 10.121

4.  Bosutinib versus Placebo for Autosomal Dominant Polycystic Kidney Disease.

Authors:  Vladimir Tesar; Kazimierz Ciechanowski; York Pei; Irina Barash; Megan Shannon; Ray Li; Jason H Williams; Matteo Levisetti; Steven Arkin; Andreas Serra
Journal:  J Am Soc Nephrol       Date:  2017-08-24       Impact factor: 10.121

5.  c-Src inactivation reduces renal epithelial cell-matrix adhesion, proliferation, and cyst formation.

Authors:  Justine Elliott; Nadezhda N Zheleznova; Patricia D Wilson
Journal:  Am J Physiol Cell Physiol       Date:  2011-04-20       Impact factor: 4.249

6.  A novel model of autosomal recessive polycystic kidney questions the role of the fibrocystin C-terminus in disease mechanism.

Authors:  Patricia Outeda; Luis Menezes; Erum A Hartung; Stacey Bridges; Fang Zhou; Xianjun Zhu; Hangxue Xu; Qiong Huang; Qin Yao; Feng Qian; Gregory G Germino; Terry Watnick
Journal:  Kidney Int       Date:  2017-07-18       Impact factor: 10.612

7.  Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.

Authors:  Miguel A Garcia-Gonzalez; Luis F Menezes; Klaus B Piontek; Junya Kaimori; David L Huso; Terry Watnick; Luiz F Onuchic; Lisa M Guay-Woodford; Gregory G Germino
Journal:  Hum Mol Genet       Date:  2007-06-16       Impact factor: 6.150

8.  Src inhibition ameliorates polycystic kidney disease.

Authors:  William E Sweeney; Rodo O von Vigier; Philip Frost; Ellis D Avner
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

9.  Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells.

Authors:  Sharon Israeli; Kurt Amsler; Nadezhda Zheleznova; Patricia D Wilson
Journal:  Am J Physiol Cell Physiol       Date:  2009-11-18       Impact factor: 4.249

10.  Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease.

Authors:  William E Sweeney; Philip Frost; Ellis D Avner
Journal:  World J Nephrol       Date:  2017-07-06
View more
  1 in total

1.  The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation.

Authors:  Claudia Dafinger; Amrei M Mandel; Alina Braun; Heike Göbel; Kathrin Burgmaier; Laura Massella; Antonio Mastrangelo; Jörg Dötsch; Thomas Benzing; Thomas Weimbs; Bernhard Schermer; Max C Liebau
Journal:  J Cell Mol Med       Date:  2020-10-28       Impact factor: 5.295

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.